Fiche publication
Date publication
avril 2025
Journal
Annals of surgical oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BACHELLIER Philippe
Tous les auteurs :
Bachellier P, de Mathelin P, Addeo P
Lien Pubmed
Résumé
Pancreatectomies with superior mesenteric artery (SMA) resection are technically challenging. With the advent of FOLFIRNOX chemotherapy, resection of the SMA is performed in selected patients with locally advanced pancreatic cancer (LAPC), in centers of excellence by highly skilled pancreatic-vascular surgeons treating a large volume of LAPCs. METHODS: The patient was a 64-year-old female with an LAPC treated with 11 cycles of FOLFIRINOX induction chemotherapy. The SMA, the superior mesenteric vein (SMV), and a replaced right hepatic artery (r-RHA) were encased. A temporary mesenterico-portal shunt (TMPS), using a 25 cm Goretex tube between the origin of the SMV and the right side of the portal vein, was used. This TMPS (1) lessens portal hypertension in case of SMV obstruction; (2) maintains adequate liver venous perfusion during dissection; (3) gives the mesentery enough mobility to avoid graft for SMA resection; and (4) avoids simultaneous venous and arterial clamping. A mesenteric approach was performed to isolate the SMA. Upon heparin bolus, the r-RHA was re-implanted on the gastroduodenal artery stump, the SMA on the aorta, the SMV on the portal vein, and the splenic vein on the left renal vein.
Mots clés
Locally advanced pancreatic adenocarcinoma, Pancreaticoduodenectomy, Superior mesenteric artery resection
Référence
Ann Surg Oncol. 2025 04 1;: